StreetAlpha.app
Home › Stocks › TMDX

TransMedics Group, Inc. (TMDX)

Healthcare
$93.91
▲ +1.84%
LAST CLOSE · NOV 17

TransMedics makes the Organ Care System, a portable device that keeps donor organs living outside the body for transplant. It last closed at $93.91 on Nov 17, up 1.84% on the day. The average 12-month price target from 6 analysts is $107.17 (+14.1% from the last close), with a high of $120.00 and a low of $85.00. Analyst consensus is Buy, based on the latest ratings from 6 firms (4 buy, 2 hold, 0 sell). Over the past 90 days StreetAlpha recorded 1 whale options trade in TMDX, 0% of them bullish and 100% bearish. In the past 30 days there were 3 dark pool prints totaling $4.1M, the largest $1.8M.

AI Auto Pilots
Is TMDX in one of our four AI portfolios? Sign in free to see

Key Stats

Last 12 months
Results
Revenue
$727.6M
+28.5% vs a year ago
Net income
$144.5M
+57.4% vs a year ago
EPS (diluted)
$3.67
+48.0% vs a year ago
Free cash flow
$44.7M
6.1% margin
Valuation
Market cap
$3.3B
34.7M shares
P/E
25.6
Price over 12 month EPS
Price to sales
4.5
Market cap over revenue
Dividend yield
None
No dividend in 12 months
Balance sheet
Cash & equivalents
$511.4M
At Sep 30
Shareholder equity
$550.7M
Shares outstanding
34.7M
At Nov 2
Fiscal year endsDecember
ExchangeNasdaq
Financials history
FY2021: $30.3M$30.3MFY2021FY2022: $93.5M$93.5MFY2022FY2023: $241.6M$241.6MFY2023FY2024: $441.5M$441.5MFY2024FY2025: $605.5M$605.5MFY2025

From TMDX's SEC filings, latest 10-Q for the period ending Sep 30, 2026 (filed Nov 5). Last 12 months adds up the four latest quarters.

Last report
Nov 5
2026 · next date not on the calendar yet
Consensus EPS forecast
—
 
Year-ago EPS
—
Not on file
Options-implied move
—
 
Analyst consensus
Buy
Based on 6 analyst ratings (90 days)
Loading…

Analyst Ratings & Price Targets

Analyst Ratings →
Consensus · 90 days
Buy
6firms
4 Buy2 Hold0 Sell
Each firm's latest rating on TMDX in the past 90 days
Average 12-month target
$107.17
▲ 14.1% upside

Based on 6 analysts who set a price target on TMDX in the past 90 days. The average target is $107.17, with a high of $120.00 and a low of $85.00, compared with the last close of $93.91.

$63$83$104$124PAST 18 TRADING DAYS12-MONTH TARGETSHIGH $120AVG $107.17LOW $85Jun 2LAST CLOSE+12 MO$63$83$104$124PAST 18 DAYSTARGETSHIGH $120AVG $107.17LOW $85Jun 2LAST CLOSE+12 MO
Highest target$120.00
Average target$107.17
Lowest target$85.00
Latest rating changes
UBSTarget raised
Nov 9Hold$77 → $88
JP MorganMaintained
Nov 7Hold$85
NeedhamTarget lowered
Nov 6Buy$208 → $110
Canaccord GenuityTarget raised
Nov 6Buy$94 → $120
Canaccord GenuityMaintained
Oct 13Buy$94
DateFirmActionRatingPrice target
Nov 9UBSTarget raisedHold$77 → $88
Nov 7JP MorganMaintainedHold$85
Nov 6NeedhamTarget loweredBuy$208 → $110
Nov 6Canaccord GenuityTarget raisedBuy$94 → $120
Oct 13Canaccord GenuityMaintainedBuy$94
Loading…

Technical Analysis

TMDX · as of the Nov 17 close · updated after every close
Bounce inside a longer downtrend, overbought

The stock is 17% above its 20 day and 14% above its 50 day average. It is 3% above its 200 day average, so the longer trend is still up. Momentum is strong (RSI 68), overbought. The nearest support is the Pivot at $93.61, and the nearest resistance the swing high (Aug 21) at $95.18.

Short trendBullish
Long trendBearish
MomentumStrong
StretchOverbought
VolatilityHigh, 5.3%/day
Key levels
$156.0052 week high+66.1%
$95.90Pivot R1+2.1%
$95.18Swing high (Aug 21)+1.4%
$93.91Last close
$93.61Pivot−0.3%
$91.62Pivot S1−2.4%
$91.22200 day average−2.9%
$85.01Swing low (Sep 18)−9.5%
$80.48100 day average−14.3%
$80.4450 day average−14.3%
$78.2820 day average−16.6%
$60.1152 week low−36.0%
Indicators
RSI (14)68.27Strong, overbought above 70Neutral
MACD4.43Above its signal lineBullish
Stochastic84.7Near the top of its rangeOverbought
ADX (14)38.1Trending up
Williams %R-11.1Oversold below −80, overbought above −20Overbought
CCI (20)97.0Oversold below −100, overbought above 100Neutral
Rate of change+39.5%Change over 10 sessionsBullish
ATR (14)$4.99Typical daily range, 5.3% of price
MA 10Above
MA 20Above
MA 50Above
MA 100Above
MA 200Above
What happened before, for TMDX

What happened before

See how TMDX did after each of today's signals in the past: how often it was higher 10 sessions later, and the typical move, next to its usual record.

November seasonalityHow TMDX usually does this month. See Seasonality

Calculated from daily prices after each close. Signals describe the chart, not where the stock will go. Past patterns often fail. Not investment advice.

Seasonality

How TMDX has done in each calendar month: the average and median return, how often each month finished higher, and every year since 2019.

Loading…

See the stocks that usually rise in November →

Whale Options Flow

90D
Total alerts
1
Bullish
0
0%
Bearish
1
100%
Date span
Aug 24 – Aug 24
Loading…

See today’s whale options flow across the market →

Dark Pool

30D
Prints
3
Notional
$4.1M
Largest print
$1.8M
Loading…

TMDX Institutional Ownership

Full report →
Fund sentiment · Q3 2026
Bullish
Strongly bearishNeutralStrongly bullish
  • ●181 buying vs 184 selling
  • ▲Held by funds +4.0 pts
  • ▲Funds holding +7
  • ▼Superinvestors: 1 added, 2 cut
  • ▲Put/call 7.06 to 3.46
Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26Q3 '26
Funds holdingHeld by funds %
Q3 2026This quarterLast quarterChange
Funds holding384377+1.9%
In funds' top 1021+100.0%
Held by funds104.3%100.3%+4.0 pts
New / increased58 / 12364 / 139−10.8%
Reduced / sold out132 / 52125 / 109−21.4%
Put/call ratio3.467.06−51.0%
Top holders, biggest buyers and sellers, 8 quarters of charts and this season's filings so far.See TMDX institutional ownership →

From SEC Form 13F filings for Sep 30, 2026. What the filings show, not a forecast: positions can be up to 45 days old and leave out short sales.

AI Auto Pilots

Paper trading

StreetAlpha runs four autonomous AI traders powered by Anthropic's Claude. Each one reads options flow, dark pool prints, insider filings, sentiment, macro signals and technicals, then makes its own trading decisions in a paper portfolio. Every decision is logged and every trade is tracked, so you can see whether TMDX is in one of them and how their past TMDX trades turned out.

TMDX in the AI portfolios
Loading…

Macro & Market News

All StreetAlpha news →

StreetAlpha hasn't covered TMDX in an article yet. Here's the latest on the wider market.

TMDX Congress Trades

All congress trades →
Trades, 12 months
3
Buys
0
0%
Sells
3
100%
People
1
Last filed Sep 22
Who traded TMDX · since 2026
Latest 3 filings
$1K – $15KTraded Jul 29, 2026Filed Sep 22, 2026
$15K – $50KTraded Jul 8, 2026Filed Sep 22, 2026
$1K – $15KTraded May 15, 2026Filed Jul 1, 2026
PersonTypeAmountTradedFiledDelay
Donald J TrumpExecutive branchSell$1K – $15KJul 29, 2026Sep 22, 202655 d
Donald J TrumpExecutive branchSell$15K – $50KJul 8, 2026Sep 22, 202676 d
Donald J TrumpExecutive branchSell$1K – $15KMay 15, 2026Jul 1, 202647 d

Members of Congress and senior officials report trades up to 45 days later, as dollar ranges. Filings show a trade happened, not why. Not investment advice.

About TransMedics Group

TransMedics Group develops medical technology for organ transplants. Its Organ Care System is a portable device that keeps donor hearts, lungs and livers in a living state outside the body, using warm, oxygenated blood instead of cold storage. The company also runs a National OCS Program that handles organ procurement and aviation and ground transport for transplant centers across the United States. Its customers are mainly transplant centers and hospitals, and the company is based in Andover, Massachusetts.

Headquarters
Andover, MA